和PEDF的影响.PDFVIP

Int Eye Sci,Vol.17,No.6,Jun. 2017摇 摇 http:/ / Tel:029 摇 Email:IJO.2000@163.com ·临床论著 · 玻璃体腔注射 Bevacizumab对 PDR患者增殖膜中CTGF 及 PEDF的影响 1 2 孙摇 磊 ,陶摇 勇 基金项目:2014年霍英东教育基金会第十四届高等院校青年教 PEDFweretested. 师基金基础性研究课题(No.141038) 誗RESULTS: The expression of CTGF and PEDF in the 作者单位:(450000)中国河南省郑州市,黄河水利委员会黄河1 proliferative membrane of the two groups were 2 expressed in the cytoplasm. The Group A showed 中心医院眼科;(100020)中国北京市,首都医科大学附属北京 朝阳医院眼科 positive expression in 38 cases, the positive rate was 作者简介:孙磊,男,本科,主治医师,研究方向:眼底病。 60郾3%. ComparedwithGroupA,the positive expression 通讯作者:孙磊.s9068633@163.com rate of CTGF in Group B (92. 1%) was significantly 收稿日期:2017-02-28摇 摇 修回日期:2017-05-12 higher (P0.05). The positive expression rates of PEDF inthe two groups were 90.5% and 95.2% respectively, Effectsof BevacizumabonCTGFandPEDF andthere was no significant difference between the two groups (P0.05). in proliferative membrane in patients 誗CONCLUSION: In patients with PDR after intravitreal with PDR injection of bevacizumab,the retinal neovascularization is significantly reduced, which is conducive to Lei Sun ,Yong